Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
James Ford, MD, medical oncologist, explains how genetic testing is being applied to understand the genetic fingerprint of an individual’s cancer and lay the foundation for the future of cancer care. Insights gained from this profiling can help identify novel drugs that specifically target the mutations driving a person’s cancer.